G-CSF VE SİKLOFOSFAMİD UYGULAMA SONRASI PERİFERİK KAN KÖK HÜCRE MOBİLİZASYON PROTOKOLÜ

Kaynaklar:

1-Apperley J, Carreras E, Gluckman E, et al. 2012. "The EBMT-ESH Handbook: Haematopoietic Stem Cell Transplantation". Sixth Edition.

2-Demirer, T., C. D. Buckner, T. Gooley, et al. 1996. "Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma." Bone Marrow Transplant 17(6):937-941.

3-Sola, C., P. Maroto, R. Salazar, et al. 1999. "Bone Marrow Transplantation: Prognostic Factors of Peripheral Blood Stem Cell Mobilization with Cyclophosphamide and Filgrastim (r-metHuG-CSF): The CD34+ Cell Dose Positively Affects the Time to Hematopoietic Recovery and Supportive Requirements after High-Dose Chemotherapy." Hematology 4(3):195-209.

4-Kumar, S., A. Dispenzieri, M. Q. Lacy, et al. 2007. "Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myeloma." Leukemia 21(9):2035-2042.

5-Alexeev S, Babenko E, Estrina M, Mikhailova N, Zubarovskaya L, Afanasyev B. fitoussi Cellular Therapy Transplantation. 2009;1(3):61-5.

6-Fermand, J. P., P. Ravaud, S. Chevret, et al. 1998. "High-dose therapy and autologous peripheral blood stem cell transplantation in multiple myeloma: up-front or rescue treatment? Results of a multicenter sequential randomized clinical trial." Blood 92(9):3131-3136.

7-Koc, O. N., S. L. Gerson, B. W. Cooper, et al. 2000. "Randomized cross-over trial of progenitor-cell mobilization: high-dose cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor plus G-CSF." J Clin Oncol 18(9):1824-1830.

8-Petrucci, M. T., G. Avvisati, G. La Verde, et al. 2003. "Intermediate-dose cyclophosphamide and granulocyte colony-stimulating factor is a valid alternative to high-dose cyclophosphamide for mobilizing peripheral blood CD34+ cells in patients with multiple myeloma." Acta Haematol 109(4):184-188.

9-Fitoussi, O., V. Perreau, J. M. Boiron, et al. 2001. "A comparison of toxicity following two different doses of cyclophosphamide for mobilization of peripheral blood progenitor cells in 116 multiple myeloma patients." Bone Marrow Transplant 27(8):837-842.

10-Hamadani, M., S. T. Kochuparambil, S. Osman, et al. 2012. "Intermediate-dose versus low-dose cyclophosphamide and granulocyte colony-stimulating factor for peripheral blood stem cell mobilization in patients with multiple myeloma treated with novel induction therapies." Biol Blood Marrow Transplant 18(7):1128-1135.